CLINICAL TRIALS PROFILE FOR GOLIMUMAB
✉ Email this page to a colleague
All Clinical Trials for golimumab
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00207714 ↗ | An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis | Completed | Centocor BV | Phase 2 | 2003-11-01 | Multicenter, randomized, double-blind, placebo-controlled, 5-arm, dose-ranging study to assess the efficacy of subcutaneous injections of Golimumab (CNTO 148), 50 or 100 mg, at either 2- or 4- week intervals in subjects with active RA despite MTX therapy. |
| NCT00207714 ↗ | An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis | Completed | Centocor, Inc. | Phase 2 | 2003-11-01 | Multicenter, randomized, double-blind, placebo-controlled, 5-arm, dose-ranging study to assess the efficacy of subcutaneous injections of Golimumab (CNTO 148), 50 or 100 mg, at either 2- or 4- week intervals in subjects with active RA despite MTX therapy. |
| NCT00207740 ↗ | A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma | Completed | Centocor BV | Phase 2 | 2004-08-01 | The purpose of this study is to evaluate the effectiveness and safety of CNTO 148 (golimumab) in patients with severe persistent asthma. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for golimumab
Condition Name
Clinical Trial Locations for golimumab
Trials by Country
Clinical Trial Progress for golimumab
Clinical Trial Phase
Clinical Trial Sponsors for golimumab
Sponsor Name
